Galstyan, Gagik R.
Tirosh, Amir
Vargas-Uricoechea, Hernando
Mabunay, Maria Aileen
Coudert, Mathieu
Naqvi, Mubarak
Pilorget, Valerie
Khan, Niaz
Clinical trials referenced in this document:
Documents that mention this clinical trial
Real-World Study on Effectiveness of Insulin Glargine U300 After Oral Antidiabetic Drug Failure in Patients with Type 2 Diabetes in the Gulf Region
https://doi.org/10.1007/s13300-024-01537-2
1028-P: Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL (gla-300) in Insulin-Naïve Patients with Type 2 Diabetes (T2DM): Interim Analysis of the ATOS Study
https://doi.org/10.2337/db20-1028-p
Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Insulin-Naïve People with Type 2 Diabetes: the ATOS Study
https://doi.org/10.1007/s13300-022-01266-4
Funding for this research was provided by:
Sanofi
Article History
Received: 1 February 2022
Accepted: 8 April 2022
First Online: 9 May 2022
Change Date: 13 October 2022
Change Type: Update
Change Details: A supplementary graphical abstract was retrospectively added to this publication.